Neurology® Podcast

Dr. Jeff Ratliff talks with Dr. John W. Winkelman about the new clinical practice guidelines for treating restless legs syndrome and periodic limb movement disorder, covering diagnosis, treatment options, and future management insights. Read the related article in the Journal of Clinical Sleep Medicine. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. John W. Winkelman about the new clinical practice guidelines for treating restless legs syndrome and periodic limb movement disorder, covering diagnosis, treatment options, and future management insights. Read the related article in the Journal of Clinical Sleep Medicine. Disclosures can be found at Neurology.org.

Gill Livingston, a professor from UCL in London, shares insights from her groundbreaking Lancet report on dementia. She discusses 14 key risk factors that could help prevent almost half of all dementia cases. Newly identified dangers like high LDL cholesterol and vision loss are also highlighted. The talk emphasizes the necessity for tailored dementia prevention strategies across different income levels and ethnicities. Livingston advocates for evidence-based approaches and the innovative role of technology in enhancing cognitive health.

Dara Albert, a child neurology expert, discusses the need for standardized training in psychogenic non-epileptic seizures. Sarah Louise Edwards and Zachary London delve into game-based learning's potential in neuroscience education, highlighting effective design and engagement strategies. Casey Albin explores how social media can enhance neurology education, emphasizing creativity and clarity. Catherine Zixis sheds light on the role of artificial intelligence in residency recruitment, discussing both its benefits and the importance of addressing bias in the selection process.

Dr. Nico Dosenbach, a neurology professor at Washington University, dives into the intricacies of the brain's action mode network and its relationship with other critical networks. He discusses how resting state functional connectivity informs our understanding of neurological disorders. Dosenbach highlights the evolutionary roles of these networks, emphasizing their significance in goal-directed behavior. The conversation also touches on innovative neuromodulation techniques that may enhance motivation and cognitive function, potentially transforming treatment for patients.

Dr. Josep Dalmau, a leader in neuroimmunology, discusses the past decade's evolution in the field. He highlights how a neuroimmunology journal has become a pivotal resource for clinical advancements. The conversation dives into AI’s potential in medical publishing and tackles complex topics like perineoplastic neurological disorders and the nuances of autoimmune epilepsy. Dalmau also clarifies GAD disorders and MOGAD, emphasizing recent breakthroughs that could transform treatment approaches for these conditions.

Dr. Adam Rodman, a physician at Beth Israel Deaconess Medical Center and expert in large language models, discusses the revolutionary impact of AI on clinical reasoning. They explore the O1 model's superior diagnostic performance compared to previous iterations like GPT-4. The conversation delves into how enhanced machine reasoning abilities could transform neurology and reduce human error. Rodman emphasizes the importance of physicians in shaping technology policy to ensure responsible integration of these tools into patient care while maintaining the human touch in medicine.

Dr. Derek Stitt talks with Dr. Miranda M. Wan about improving training and public awareness to optimize palliative care for patients with neurologic conditions. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Adrian Budhram, a neurologist known for his expertise in autoimmune encephalitis, discusses the complexities of cerebrospinal fluid (CSF) analysis after traumatic lumbar punctures. He highlights the challenges neurologists face with red and white blood cell contamination and the research gaps in correction factors for accurate diagnoses. Patient anxiety during these procedures also becomes a focal point, emphasizing the importance of effective doctor-patient communication. Ultimately, the conversation stresses the significance of clinical judgment in interpreting CSF results.

Dr. Simon Ducharme, a senior author from McGill University, dives into intriguing findings on sleep dysfunction related to genetic frontotemporal dementia (FTD). He discusses the impact of MAPT gene mutations on sleep patterns and emphasizes the role of genetic testing for early diagnosis. Ducharme highlights the association between hypothalamic structural changes and sleep issues, along with the need for effective treatment strategies. He also explores the significance of managing sleep disorders in improving care for FTD patients.